https://scholars.lib.ntu.edu.tw/handle/123456789/463768
標題: | Risk of Hypoglycemia and Concomitant Use of Repaglinide and Clopidogrel: A Population-Based Nested Case-Control Study | 作者: | Wei, Y. FANG-JU LIN SHIN YI LIN CHI-CHUAN WANG |
公開日期: | 2019 | 出版社: | WILEY | 卷: | 106 | 期: | 6 | 起(迄)頁: | 1346 | 來源出版物: | Clinical Pharmacology and Therapeutics | 摘要: | © 2019 The Authors Clinical Pharmacology & Therapeutics © 2019 American Society for Clinical Pharmacology and Therapeutics This nested case-control study evaluated the potential interaction between repaglinide and clopidogrel. Cases were defined by inpatient admissions or emergency department visits due to hypoglycemia. Concomitant use of repaglinide and clopidogrel within 3 days before the hypoglycemic event was the exposure of interest. For each case, up to four controls were randomly selected and matched by age, sex, type of glinide used (repaglinide or nateglinide), and time since cohort entry to the index date. Hypoglycemic risk was estimated by conditional logistic regressions. Concomitant use of repaglinide and clopidogrel was associated with an increased risk of hypoglycemia compared with repaglinide alone (adjusted odds ratio: 2.42; 95% confidence interval: 1.75−3.35). No significant associations were found with the two negative control object drug concomitants: nateglinide and clopidogrel and repaglinide and aspirin (without clopidogrel use). Our study suggests drug interaction between clopidogrel and repaglinide is clinically relevant and could increase the risk for hypoglycemia. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/463768 | ISSN: | 0009-9236 1532-6535 |
DOI: | 10.1002/cpt.1556 65134559 |
SDG/關鍵字: | acetylsalicylic acid; clopidogrel; gemfibrozil; metformin; nateglinide; repaglinide; sulfonylurea; acetylsalicylic acid; antidiabetic agent; antithrombocytic agent; carbamic acid derivative; clopidogrel; nateglinide; piperidine derivative; repaglinide; aged; Article; case control study; cohort analysis; combination drug therapy; comorbidity; controlled study; diabetes mellitus; dyslipidemia; female; human; hypoglycemia; major clinical study; male; monotherapy; population based case control study; priority journal; drug interaction; hypoglycemia; middle aged; Aged; Aspirin; Carbamates; Case-Control Studies; Clopidogrel; Drug Interactions; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Nateglinide; Piperidines; Platelet Aggregation Inhibitors |
顯示於: | 臨床藥學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。